In 2016, a series of compounds inducing pyrimidine depletion, i.e., DHODH inhibitors, were found to promote differentiation in several AML models [1], underlying the wide influence of metabolism on cancer cells’ behavior. This evidence concerns the gene DHODH and cancer.